Relmada Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
RLMD Nasdaq 2834 www.relmada.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Relmada Therapeutics, Inc.

5 Small Drug Stocks Poised to Benefit From a Biotech Recovery - Sep 14th, 2026 7:30 am
Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference - Sep 1st, 2026 6:00 am
After Plunging 18.5% in 4 Weeks, Here's Why the Trend Might Reverse for Relmada Therapeutics (RLMD) - Aug 31st, 2026 7:35 am
Here's Why Relmada Therapeutics (RLMD) Is a Great 'Buy the Bottom' Stock Now - Aug 25th, 2026 7:55 am
Down 29.6% in 4 Weeks, Here's Why Relmada Therapeutics (RLMD) Looks Ripe for a Turnaround - Aug 11th, 2026 7:35 am
Relmada Therapeutics Q2 Earnings Call Highlights - Aug 7th, 2026 5:03 am
Relmada Therapeutics Inc (RLMD) (Q2 2026) Earnings Call Highlights: Strong Phase 2 Data and FDA ... - Aug 6th, 2026 11:09 pm
Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - Aug 6th, 2026 2:05 pm
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer - Jul 28th, 2026 6:30 am
Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 - Jul 16th, 2026 5:05 am
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes - Jun 29th, 2026 5:00 am
Relmada Therapeutics (RLMD): 10 Best Growth Stocks Under $30 to Buy Now - Jun 19th, 2026 1:01 am
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program - Jun 11th, 2026 5:00 am
Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference - May 28th, 2026 5:00 am
Relmada Therapeutics, Inc. Q1 2026 Earnings Call Summary - May 13th, 2026 6:30 am
Relmada Therapeutics Inc (RLMD) Q1 2026 Earnings Call Highlights: Strong Financial Position and ... - May 12th, 2026 11:02 pm
Relmada Therapeutics Q1 Earnings Call Highlights - May 12th, 2026 8:06 pm
Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - May 12th, 2026 2:05 pm
Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026 - May 6th, 2026 5:00 am